Genentech Starts Pulling Back Psoriasis Drug

Posted on by

Raptiva, which had 2008 sales of $108 million in the United States, has been linked to a brain infection.

Original post by By REUTERS

Share and Enjoy:
  • services sprite Genentech Starts Pulling Back Psoriasis Drug
  • services sprite Genentech Starts Pulling Back Psoriasis Drug
  • services sprite Genentech Starts Pulling Back Psoriasis Drug
  • services sprite Genentech Starts Pulling Back Psoriasis Drug
  • services sprite Genentech Starts Pulling Back Psoriasis Drug
  • services sprite Genentech Starts Pulling Back Psoriasis Drug
  • services sprite Genentech Starts Pulling Back Psoriasis Drug
  • services sprite Genentech Starts Pulling Back Psoriasis Drug
  • services sprite Genentech Starts Pulling Back Psoriasis Drug
  • services sprite Genentech Starts Pulling Back Psoriasis Drug
  • services sprite Genentech Starts Pulling Back Psoriasis Drug

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>